Drug Database
Back to search

France· FR:62119972

MOVENTIG 12,5 mg, comprimé pelliculé

A naloxegol product containing oxalate de naloxégol, registered in France by GRUNENTHAL, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A06AH03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedMOVENTIG 12,5 mg, comprimé pelliculéATCA06AH03REGISTER NO.FR:62119972PACKS LISTED3CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about oxalate de naloxégolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Naloxegol is registered in 15 of 19 countries.

Countries holding a registration under ATC A06AH03 (naloxegol), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose
Search naloxegol products by name

Naloxegol · ATC A06AH03

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of naloxegol costs, country by country.

Normalised to the WHO defined daily dose (25 mg), the median price runs from $3.62 in Italy to $5.84 in Spain — a ×1.6 gap.

  • France: $3.80 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Naloxegol · price per daily dose (25 mg)

USD · FX 28 Sept 2026

  • ES Spain$5.84
  • CH Switzerland$5.75
  • FR France$3.80
  • IT Italy$3.62
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
OXALATE DE NALOXÉGOL
Manufacturer
GRUNENTHAL
Country
France (FR)
ATC code
A06AH03
ATC class
Naloxegol
Defined daily dose
25 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 3

2 priced
  • cip13
    3400930004609
    plaquette(s) aluminium de 30 comprimé(s)
    EUR 66.83
  • cip13
    3400930130254
    30 plaquette(s) aluminium de 1 comprimé(s)
    EUR 66.83
  • cip13
    3400955001867
    90 plaquette(s) aluminium de 1 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

204 interactions on record for naloxegol.

Graded by severity as the source publishes them — 66 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check naloxegol against other medicinesHow interaction checks work

Naloxegol · interactions on record

204 records

  • 66 severe
  • 57 moderate
  • 81 minor

Most severe, free to view

  • AprepitantA04AD12severe
  • DanazolG03XA01severe
  • LonafarnibA16AX20severe
  • BerotralstatB06AC06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Naloxegol in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naloxegol products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Moventig
  • Iceland · Moventig
  • Liechtenstein · Moventig
  • Norway · Moventig

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/adefab0c-bcf2-4032-8616-c95e7476d96c
GET /v1/drugs/adefab0c-bcf2-4032-8616-c95e7476d96c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62119972",
  "date_amm": "2014-12-08",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/14/962",
  "substance": "OXALATE DE NALOXÉGOL",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about naloxegol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console